US Patent Issued to Chugai Seiyaku on May 19 for "Method for predicting sensitivity of cancer cell to helicase inhibitor" (Japanese Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,880, issued on May 19, was assigned to Chugai Seiyaku K.K. (Tokyo).

"Method for predicting sensitivity of cancer cell to helicase inhibitor" was invented by Hiroshi Sakamoto (Kanagawa, Japan), Kenji Kashima (Kanagawa, Japan), Kiyomoto Ogasawara (Kanagawa, Japan), Yuki Ohte (Kanagawa, Japan) and Mayumi Soga (Kanagawa, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a method for predicting sensitivity of a cancer cell to a helicase inhibitor, the method comprising the step of: predicting a cancer cell having at least one mutation detected selected from the first group consisting of TTK mutation and RAD 50 mutation, as having sensitivit...